A Greenberg

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Vasopressin receptor antagonists
    A Greenberg
    Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Kidney Int 69:2124-30. 2006
  2. ncbi request reprint Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
    Arthur Greenberg
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Kidney Dis 50:904-7. 2007
  3. ncbi request reprint Familial hypocalciuric hypercalcemia in the donor and recipient of a living related donor kidney transplant
    J E Novak
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Am J Transplant 7:718-21. 2007
  4. ncbi request reprint Diuretic complications
    A Greenberg
    Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Med Sci 319:10-24. 2000
  5. ncbi request reprint Viral infections after renal transplantation
    S R Smith
    Divisions of Nephrology and Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
    Am J Kidney Dis 37:659-76. 2001
  6. ncbi request reprint Hyponatremia treatment guidelines 2007: expert panel recommendations
    Joseph G Verbalis
    Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia 20007, USA
    Am J Med 120:S1-21. 2007
  7. ncbi request reprint Hyperkalemia: a review
    Kimberley J Evans
    Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, NC 27710, USA
    J Intensive Care Med 20:272-90. 2005
  8. ncbi request reprint Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation
    Ruediger W Lehrich
    Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, NC 27710, USA
    Hum Immunol 66:350-8. 2005
  9. ncbi request reprint Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection
    Paulo N Rocha
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Transplantation 75:1490-5. 2003
  10. ncbi request reprint Postinfectious glomerulonephritis in renal allograft recipients
    Troy J Plumb
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Transplantation 82:1224-8. 2006

Research Grants

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Vasopressin receptor antagonists
    A Greenberg
    Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Kidney Int 69:2124-30. 2006
    ..Results of long-term trials to determine the ability of VRAs to reduce morbidity or mortality in congestive heart failure or to slow the progression of polycystic kidney disease are awaited with great interest...
  2. ncbi request reprint Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
    Arthur Greenberg
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Kidney Dis 50:904-7. 2007
  3. ncbi request reprint Familial hypocalciuric hypercalcemia in the donor and recipient of a living related donor kidney transplant
    J E Novak
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Am J Transplant 7:718-21. 2007
    ..The excellent posttransplant clinical course of both recipient and donor is emphasized...
  4. ncbi request reprint Diuretic complications
    A Greenberg
    Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Med Sci 319:10-24. 2000
    ..Diuretics are widely used and generally safe, but like any therapeutic agents, they may cause side effects...
  5. ncbi request reprint Viral infections after renal transplantation
    S R Smith
    Divisions of Nephrology and Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
    Am J Kidney Dis 37:659-76. 2001
    ..This review summarizes the natural history, diagnosis, prevention, and treatment of many common viral infections after renal transplantation...
  6. ncbi request reprint Hyponatremia treatment guidelines 2007: expert panel recommendations
    Joseph G Verbalis
    Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia 20007, USA
    Am J Med 120:S1-21. 2007
    ..This review presents their conclusions, including identification of appropriate treatment populations and possible future indications for aquaretic AVPR antagonists...
  7. ncbi request reprint Hyperkalemia: a review
    Kimberley J Evans
    Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, NC 27710, USA
    J Intensive Care Med 20:272-90. 2005
    ..Hyperkalemia is easily diagnosed, and rapid and effective treatments are readily available. Unfortunately, treatment of this life-threatening condition is often delayed or insufficiently attentive or aggressive...
  8. ncbi request reprint Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation
    Ruediger W Lehrich
    Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, NC 27710, USA
    Hum Immunol 66:350-8. 2005
    ..IVIG in combination with PP is an effective treatment for AHR. Graft survival in this setting is similar to graft survival in patients with ACR...
  9. ncbi request reprint Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection
    Paulo N Rocha
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Transplantation 75:1490-5. 2003
    ..Our study compared the renal allograft survival of patients with AHR treated with plasmapheresis (PP) and intravenous immunoglobulin (IVIG) with allograft survival in patients with acute cellular rejection (ACR)...
  10. ncbi request reprint Postinfectious glomerulonephritis in renal allograft recipients
    Troy J Plumb
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Transplantation 82:1224-8. 2006
    ..All regained renal function with treatment of their known or suspected infections and without specific therapies for their glomerulonephritis, including corticosteroids...
  11. ncbi request reprint Kidney disease other than renal crisis in patients with diffuse scleroderma
    Virginia D Steen
    Georgetown University, Washington, DC 20007, USA
    J Rheumatol 32:649-55. 2005
    ..To determine the frequency and severity of kidney abnormalities in patients with diffuse scleroderma...
  12. ncbi request reprint Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN)
    Christopher G Acker
    Renal Electrolyte Division, University of Pittsburgh Medical Center, PA, USA
    Am J Transplant 2:57-61. 2002
    ..Long-term graft function is impaired in patients who experience post-transplant DGF compared to those who have good initial function...
  13. doi request reprint When is it appropriate to use vasopressin receptor antagonists?
    Ruediger W Lehrich
    Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27710, USA
    J Am Soc Nephrol 19:1054-8. 2008
    ..Beneficial effects beyond changing serum tonicity and alternative uses, such as in polycystic kidney disease, need further exploration. This commentary discusses the current and potential indications for use of VRA...

Research Grants1

  1. Hemodialysis Vascular Access Clinical Trial Consortium
    Arthur Greenberg; Fiscal Year: 2006
    ..This study is an attempt to reduce patient inconvenience and health care system expense by developing methods to prolong the lifespan of these connections. ..